Related Experiment Video
Updated: Jul 17, 2026
Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration
Published on: May 29, 2015
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
Gaorav P Gupta1, Don X Nguyen, Anne C Chiang
1Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Abstract:
Metastasis entails numerous biological functions that collectively enable cancerous cells from a primary site to disseminate and overtake distant organs. Using genetic and pharmacological approaches, we show that the epidermal growth factor receptor ligand epiregulin, the cyclooxygenase COX2, and the matrix metalloproteinases 1 and 2, when expressed in human breast cancer cells, collectively facilitate the assembly of new tumour blood vessels, the release of tumour cells into the circulation, and the breaching of lung capillaries by circulating tumour cells to seed pulmonary metastasis. These findings reveal how aggressive primary tumorigenic functions can be mechanistically coupled to greater lung metastatic potential, and how such biological activities may be therapeutically targeted with specific drug combinations.
Insights
This study reveals how epiregulin, COX2, and matrix metalloproteinases promote breast cancer metastasis by aiding tumor blood vessel formation, cell release, and lung capillary invasion. These findings offer new therapeutic targets for reducing lung metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis is a complex process involving cancer cell dissemination from a primary tumor to distant organs.
- Understanding the molecular mechanisms driving metastasis is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the roles of epiregulin, cyclooxygenase-2 (COX2), and matrix metalloproteinases (MMPs) in facilitating breast cancer metastasis.
- To elucidate the mechanistic links between primary tumor functions and lung metastatic potential.
Main Methods:
- Utilized genetic and pharmacological approaches in human breast cancer cells.
- Assessed the impact of epiregulin, COX2, and MMPs on angiogenesis, tumor cell circulation, and lung capillary extravasation.
Main Results:
- Epiregulin, COX2, and MMPs (1 and 2) expression in breast cancer cells collectively promotes new blood vessel assembly (angiogenesis).
- These factors facilitate the release of tumor cells into the bloodstream.
- They also enable circulating tumor cells to breach lung capillaries, leading to pulmonary metastasis.
Conclusions:
- Aggressive primary tumor functions are mechanistically coupled to increased lung metastatic potential.
- Targeting epiregulin, COX2, and MMPs, potentially with drug combinations, may offer therapeutic strategies to inhibit metastasis.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:24Regulation of Angiogenesis and Blood Supply